The trademark application UROCIN was filed by Apogepha Arzneimittel GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on December 7, 2023, and it was registered by office on March 15, 2024 without any oppositions.
It was designated 'Basic Application' for International Application 1782219 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).